http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1765393-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81a8c78d34601fc548f8bc1c1aaddb44 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-235 |
filingDate | 2005-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75bb2dbf5b49a2138822db9daec9d23d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1511a749f29ba1259f7ddc24fcceedab |
publicationDate | 2007-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1765393-A1 |
titleOfInvention | Method of enhancing the effect of anti cancer drug by inhibition of the activity of ampk |
abstract | Provided is herein a method for enhancing therapeutic effects of an anti-cancer drug by inhibition of AMPK activity in conjunction with use of an anti-cancer drug for inhibiting proliferation and/or metastasis of cancer. The method in accordance with the present invention can significantly enhance therapeutic effects of an anti-cancer drug via inhibition of AMPK activity and therefore is very useful in inhibition of cancer proliferation and metastasis, utilizing anti-cancer drugs. Further, the present invention enables use of conventional anti-cancer drugs for cancer cells having drug- resistance to such anti-cancer drugs. |
priorityDate | 2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.